ClinicalTrials.gg
CompletedNCT00215410Updated Nov 11, 2010

Study in Patients With Asthma

A Phase 2 interventional study of Formoterol Fumarate in Asthma, sponsored by Dey. Completed at 12 sites in United States. Open to participants aged 5 Years to 12 Years. Per ClinicalTrials.gov, last updated 2010-11-11.

Sponsored by Dey (part of Viatris Inc.) · Phase 2, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
5 Years to 12 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-18

Among 86 studies testing formoterol in Asthma — 2 open to participants now, 2 under way, 2 of them phase 3. formoterol · Asthma.

Enrollment
63rd of 85
36 · median 100
Phase 2
17 of 86
none open now
Registered
2nd of 86
by date
Lead sponsor
4 of 86
Dey

Among the 86 studies testing formoterol in Asthma, this one is the 63rd largest by enrollment of the 85 interventional ones that give a count, is one of 17 in phase 2, and was the 2nd registered.

Asthma

4,850 studies on the registry are indexed under Asthma; 604 are open to participants now.

Browse Asthma studies →

Open to participants now

2 of the 86 studies testing formoterol in Asthma are open now, in 2 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

About formoterol

formoterol: first FDA approval 2001 (FORADIL), first EMA approval 2014. What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 415 Asthma studies recruiting now, 140 (34%) set no upper age limit and 204 (49%) stop at 75 or younger; 145 take children under 18; 105 take healthy volunteers.

This study: 5 Years to 12 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 86 studies testing formoterol in Asthma, or all of them as a file.
02

Study summary

The purpose of this study is to determine the most safe and effective dose of the investigational drug in comparison with a control drug and placebo.

03

Conditions studied

  • Asthma

Browse trials for

Keywords

  • Asthma
  • Formoterol
  • Fumarate
04

Who can participate

Ages eligible
5 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children with a history of asthma
  • Written guardian approval

Exclusion criteria

Exclusion Criteria:

  • Current or recent asthma exacerbation, requiring hospitalization
  • History of smoking
  • Debilitating or systemic and/or life-threatening diseases.
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double
Enrollment
36 participants

Interventions

06

What researchers measure

Primary outcomes

  1. Measure of lung function

Secondary outcomes

  1. Change in lung function, as well as vital signs

  2. Physical Exam results, AE reporting, etc

07

Study locations

12 sites
  • Research Site
    Little Rock, Arkansas 72205, United States
  • Research Site
    Long Beach, California 90806, United States
  • Research Site
    Mission Viejo, California 92691, United States
  • Research Site
    Newport Beach, California 92660, United States
  • Research Site
    Orange, California 92888, United States
  • Research Site
    Vista, California 92084, United States
  • Research Site
    Englewood, Colorado 80112, United States
  • Research Site
    Oklahoma, Oklahoma 73120, United States
  • Research Site
    Medford, Oregon 97504, United States
  • Research Site
    Portland, Oregon 97213, United States
  • Research Site
    Fort Worth, Texas 76107, United States
  • Research Site
    Houston, Texas 77054, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 11, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00215410
Lead sponsor
Dey
First posted
Sep 22, 2005
Primary completion
Oct 2003
Completion
Oct 2005
Last update
Nov 11, 2010
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Formoterol

Start the discussion